NCT07611110: AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- State
- Under way
- Phase
- Phase 3
- People
- 670 planned
- Started
- 4 May 2026
- Primary completion
- 4 Jun 2029
- Arms
- Arm A
- Results
- None posted
- 4 May 2026: Trial started
- 28 May 2026: Trial registered